HCPLive Network

Hyperbaric Oxygen Improves Function Long After Stroke

 
FRIDAY, Jan. 25 (HealthDay News) -- Hyperbaric oxygen therapy (HBOT) significantly improves neurological function and quality of life in people who had a stroke up to three years earlier, according to a study published online Jan. 15 in PLOS One.

Shai Efrati, M.D., from the Assaf Harofeh Medical Center in Zerifin, Israel, and colleagues treated 74 patients who had suffered a stroke six to 36 months earlier with 40 sessions of HBOT over two months (five days a week, 90 minutes, 100 percent oxygen), either immediately or after a two-month period of no treatment.

The researchers found that HBOT significantly improved neurological function and quality of life, while no improvement was observed during the two-month untreated period. Improvements in brain metabolism, as determined by single photon emission computed tomography, correlated with clinical improvement. Brain activity improved in areas that contained live cells but low activity.

"To conclude, in this study we provide, for the first time, convincing results demonstrating that HBOT can induce significant neurological improvement in post-stroke patients," Efrati and colleagues write. "The neurological improvements in a chronic late stage demonstrate that neuroplasticity can be operative and activated by HBOT even long after acute brain insult."
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 
Further Reading
Although patients are expressing more of an interest in accessing their health information online, just a third of patients have access to patient portals, and the rest either don't have access or are not sure if they do.
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
As the 2 Americans stricken with Ebola continue to receive treatment in Atlanta, a new potential case of the deadly virus has been reported in California.
For patients with heart failure with reduced ejection fraction, cardiac resynchronization therapy and implantable cardioverter-defibrillator therapies are associated with clinical benefit, irrespective of patient race/ethnicity, according to a study published in the Aug. 26 issue of the Journal of the American College of Cardiology..
For preadolescent children, white matter structure varies with fitness level, according to a study published online Aug. 19 in the Frontiers of Neuroscience.
High uranium exposure is associated with systemic lupus erythematosus, according to a study published online Aug. 7 in Arthritis & Rheumatology.
More Reading